How much funding has iFAST Diagnostics raised?

iFAST Diagnostics funding information is not publicly available.

iFAST Diagnostics Analysis

What is iFAST Diagnostics?

Rapid antimicrobial susceptibility testing technology

Location

Whiteley, United Kingdom

Employees

11-50

Founded

2022

Product Features & Capabilities

Antimicrobial susceptibility testing
iFAST reader for rapid results
Minimum Inhibitory Concentration (MIC) analysis for up to 15 drugs

Use Cases

Provide results in under 3 hours for blood samples; Analyze raw urine samples in under 4 hours; Perform up to 25 tests per day per reader; Determine resistant/susceptible outputs for clinicians; Support clinical studies in hospitals

Other Considerations

Raised $6.5M in seed funding led by KHP Ventures; UK regulatory approval expected in Q4 2025; Selected for Healthcare Innovation Consortium’s AMR Innovation Programme

See something that needs updating? Suggest edits to this profile.

iFAST Diagnostics Analysis

What is iFAST Diagnostics?

Product Features & Capabilities

Use Cases

Other Considerations

Platform Links

Loading company information...

iFAST Diagnostics Analysis

What is iFAST Diagnostics?

Product Features & Capabilities

Use Cases

Other Considerations

Platform Links